LAMP Trademark

Trademark Overview


On Thursday, February 6, 2020, a trademark application was filed for LAMP with the United States Patent and Trademark Office. The USPTO has given the LAMP trademark a serial number of 88787581. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by CytoDyn Inc.. The LAMP trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

providing a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

scientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
lamp

General Information


Serial Number88787581
Word MarkLAMP
Filing DateThursday, February 6, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2020

Trademark Statements


Goods and Servicestherapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Goods and Servicesproviding a website featuring information in the field of antibodies for use in targeting the CCR5 cell receptor; providing health and medical information, namely, providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
Goods and Servicesscientific research consulting services in the field of immunology; scientific research consulting services in the field of antibodies for use in targeting the CCR5 cell receptor; scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services; medical research and medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor; medical research and analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 10, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 10, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCytoDyn Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, WA 98660

Party NameCytoDyn Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, WA 98660

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2022SOU EXTENSION 3 GRANTED
Thursday, October 27, 2022SOU EXTENSION 3 FILED
Thursday, October 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 2 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 2 FILED
Wednesday, April 27, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 25, 2021SOU EXTENSION 1 GRANTED
Monday, October 25, 2021SOU EXTENSION 1 FILED
Monday, October 25, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, March 14, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, December 1, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 29, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 28, 2020NON-FINAL ACTION E-MAILED
Saturday, March 28, 2020NON-FINAL ACTION WRITTEN
Saturday, March 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 28, 2020NON-FINAL ACTION E-MAILED
Saturday, March 28, 2020NON-FINAL ACTION WRITTEN
Thursday, March 26, 2020ASSIGNED TO EXAMINER
Monday, February 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2020NEW APPLICATION ENTERED